Developer docs
API playgroundTry for free, no card

Search company profiles

Exocel Bio

Full company profile

uuid000a8ul

Namestring
Exocel Bio
Legal namestring
Exocel Bio
Websiteurl
exocelbio.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Exocel Bio is a privately held biotechnology company that designs and manufactures mesenchymal stem cell (MSC)-derived exosome products for professional regenerative aesthetics. The company operates under cGMP and ISO standards at a state-of-the-art GMP cleanroom facility located at the Pennsylvania Biotechnology Center in Doylestown, and sells exclusively to licensed clinicians rather than consumers. Its core brand, exovex, spans exovex Skin (5B, 12B, 25B exosome concentrations), exovex+ Skin (5 Trillion EVs with a multi-component bioactive complex), and exovex+ Hair (7B, 15B, 30B concentrations), plus research-grade exosomes (75B, 100B, 450B) and a custom concentration service for academic and biotech researchers.

The company's technical differentiation rests on a proprietary 9-step manufacturing process, tangential flow filtration for large-scale GMP-compatible isolation, and third-party validation using ExoView chip assays, mass spectrometry, NGS, PCR, MudPIT, and NTA to verify exosome identity (CD9, CD63, CD81 markers), purity, and potency. Research claims include over 500 specific growth factors and biomolecular cargo including mRNA, miRNA, collagen, keratin, and Wnt-pathway proteins. The company is exploring novel enhancements such as simulated microgravity and hypoxic culture conditions, presented at the SELECTBIO Space Summit 2025.

Exocel Bio generates revenue through one-time purchases of professional exosome serums and research-grade exosomes sold direct to clinics, medical spas, hair restoration practices, and academic institutions via a contact-based, quote-driven sales model. Distribution is domestic US only, supported by monthly Exovex Experiences webinars, Peer-to-Peer Physician Forums, and active participation in aesthetic and extracellular vesicle industry conferences. Scientific advisory board members from Harvard Medical School, Mount Sinai, and other leading institutions lend clinical and translational credibility to the offering.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
exosome skincare, regenerative aesthetics, MSC-derived exosomes, professional aesthetic biologics, hair restoration serums
Industry3 codes
PRIMARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SECONDARYCRABAAAK
Professional/Backbar Skincare (Esthetician & Spa Use)
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Perfumes, Cosmetics & Other Toilet Preparations2844
Product category
Regenerative Aesthetics Biologics
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Professional Exosome Products
TypeOne Time License
Description

Sale of exovex branded exosome serums and solutions to licensed aesthetic clinics and medical professionals. Products include exovex Skin (5B, 12B, 25B concentrations) and exovex+ Hair (7B, 15B, 30B concentrations) and exovex+ Skin (5 Trillion EVs). Professional-use only, sold directly to practices.

exocelbio.com
2Custom Concentration Exosomes
TypeOne Time License
Description

Research-use exosomes at custom concentrations for academic and biotech research institutions. Products made to order with 3-4 week lead time, targeting specific concentration requirements for research or therapeutic applications.

exocelbio.com
3Research Exosome Products
TypeOne Time License
Description

Sale of bulk research-grade exosomes (75B, 100B, 450B concentrations) for research-only applications. Purified active exosomes suspended in medical-grade saline, free of additives and chemicals.

exocelbio.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details7 tiers
1REVIVE - 5 Billion exosomes for face revitalization
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Entry-level concentration for basic facial applications. FOR PROFESSIONAL USE ONLY.

exocelbio.com
2RENEW - 12 Billion exosomes for face and neck applications
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Mid-tier concentration addressing face, neck tone, texture, and elasticity. FOR PROFESSIONAL USE ONLY.

exocelbio.com
3REVEAL - 25 Billion exosomes for broad coverage
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

High-concentration for broader coverage: face, neck, decollete, and hands. FOR PROFESSIONAL USE ONLY.

exocelbio.com
4REFINE - 75 Billion exosomes for research use
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Research-use only concentration. 75B exosomes in 5ml vial packed with mRNA, miRNA, proteins, and growth factors.

exocelbio.com
5RESTORE - 100 Billion exosomes for research use
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Research-use only concentration. 100B exosomes in 5ml vial with comprehensive biomolecular profile.

exocelbio.com
6EXOVEX+ HAIR - 7/15/30 Billion variants
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Hair rejuvenation serum with multi-factor complex including microRNAs, peptides, vitamins, growth factors, cytokines, and Wnt pathway proteins. FOR PROFESSIONAL USE ONLY.

exocelbio.com
7exovex+ SKIN - 5 Trillion EVs
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Advanced formulation delivering 5 Trillion Extracellular Vesicles with 6 bioactive components including Pure Active Intact Exosomes, Methylcobalamin (Vitamin B12), Bioactive Peptides, Cytokines and Growth Factors. 5ML professional serum. FOR PROFESSIONAL USE ONLY.

exocelbio.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1exovex+ SKIN
Description

Professional-use exosome serum for skin rejuvenation, delivering 5 trillion extracellular vesicles with pure active intact exosomes, methylcobalamin, bioactive peptides, cytokines and growth factors.

exocelbio.com
+2 more records
Core offering1 text field

Exocel Bio designs, manufactures, and sells exovex-branded MSC-derived exosome serums and solutions for professional skin rejuvenation and hair restoration, along with research-grade exosome products for academic and biotech use. All products are manufactured under cGMP and ISO standards at the Pennsylvania Biotechnology Center and are sold exclusively to licensed medical professionals and verified research institutions, not directly to consumers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Exocel Bio offers a unified portfolio of exosome-based regenerative products centered on its exovex® brand. The core offering includes exovex® Skin (available in 5B, 12B, and 25B concentrations) and exovex+ Skin (5 Trillion EVs with enhanced peptide complex) for skin rejuvenation, and exovex+ Hair (7B, 15B, 30B) for hair restoration. Supporting the professional product line are research-grade exosomes in 75B, 100B, and 450B concentrations, plus a custom concentration service for researchers. All products derive from MSC-derived exosomes and are intended exclusively for professional use.

Product and service5 records
1exovex Skin
CategoryProfessional Skin Rejuvenation Serum
Description

Professional-use exosome serum designed to support visibly revitalized, healthier-looking skin through advanced cellular science. Powered by purified MSC-derived exosome-rich components, growth factors, and mRNA elements. Available in three concentrations: 5 Billion, 12 Billion, and 25 Billion exosomes per vial. For professional use only by licensed practitioners.

2exovex+ Skin
CategoryProfessional Skin Rejuvenation Serum
Description

Advanced professional skin rejuvenation serum delivering 5 Trillion Extracellular Vesicles with six bioactive components including Pure Active Intact Exosomes, Methylcobalamin (Vitamin B12), Bioactive Peptides, Cytokines, and Growth Factors in a 5ML professional serum. Manufactured under GMP standards with sterility and endotoxin testing and full manufacturing traceability in a GMP-certified facility in the USA. For professional use only.

3exovex+ Hair
CategoryProfessional Hair Restoration Serum
Description

Professional hair treatment formulation with multi-factor complex including selected microRNAs (miR-10a, miR-21-5p, miR-26a-5p, miR-31, miR-146a-5p, miR-218-5p), peptides, vitamins, growth factors (FGF1/2/7/10, IGF-1/2, VEGFA, PDGF-A/B), cytokines, and Wnt pathway proteins. Available in 7 Billion, 15 Billion, and 30 Billion concentrations. For professional use only.

4Research Exosomes (For Research Only)
CategoryResearch-Grade Exosome Reagent
Description

Highly concentrated, purified active exosomes suspended in medical-grade saline for research purposes. Free of additives and chemicals, available in 75 Billion, 100 Billion, and 450 Billion concentrations in 5ml vials, containing 500+ specific growth factors along with mRNA, miRNA, and proteins including collagen, keratin, elastin, and fibulin. For research use only.

5Custom Concentration Exosomes
CategoryCustom Research Service
Description

Custom concentration exosome service for research applications, allowing researchers and biotech institutions to specify exact concentration requirements tailored to their research or therapeutic applications. Made-to-order with 3-4 week lead time.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Renowned third-party collaborator and testing partner. Collaborates on scientific research and validation of exosome technology applications in regenerative medicine.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborating institution located at Pennsylvania Biotechnology Center. Provides research infrastructure and institutional partnership for exosome development. Dr. Aejaz Sayeed established institutional partnership between Blumberg Institute and Capital Health Hospital.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Renowned academic collaborator contributing to scientific foundation of company's R&D efforts in exosome research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partner contributing to company's scientific research and development initiatives in regenerative medicine.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

International academic collaborator contributing to scientific foundation and ongoing research and development efforts.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Selected as finalist in global pitch competition hosted in collaboration with WashU, recognizing innovative biotech solutions. Presentation addressed blood-brain barrier challenges and novel exosome-based approach for epilepsy treatment.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Conference organizer for The Space Summit 2025 and Extracellular Vesicles & Lipid Nanoparticles tracks. Platform for presenting research on space microgravity and hypoxia conditions for MSC-derived exosome enhancement.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Industry symposium on extracellular vesicles R&D. Natalia Tumidajski joined panel discussion on emerging technologies and bridging scientific innovation with scalable GMP manufacturing.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global aesthetics leader (Botox, SkinMedica, CoolSculpting) with massive professional channel reach. Represents the broad incumbent benchmark that Exocel Bio's professional aesthetic clinic customers already transact with daily.

2BENEV
TypeDirect peer
Description

US aesthetics and regenerative medicine company distributing exosome-based professional skincare lines. Comparable product portfolio, distribution model (B2B professional channel), and concentration-tier approach to exovex Skin/Hair.

TypeDirect peer
Description

Korea-based pioneer in stem cell-derived exosome cosmetics and therapeutics with established US distribution. Directly comparable as an MSC-derived exosome company targeting the same aesthetic dermatology channel with overlapping scientific claims and SKUs.

TypeEmerging player
Description

US-based regenerative medicine company developing MSC-derived biologic products for wound care and orthopedic indications. Comparable emerging player in the broader exosome/MSC regenerative-medicine category Exocel Bio aspires to enter beyond aesthetics.

TypeDirect peer
Description

US-based aesthetics company commercializing placental-derived exosome products for skin rejuvenation and hair restoration. Closest direct competitor with overlapping product positioning, channel (aesthetic practices), and regenerative-biology messaging.

TypeOthers
Description

Regenerative medicine company (Apligraf, Dermagraft, NuShield) selling wound healing and surgical biologics. Comparable as an adjacent regenerative-medicine player whose wound-care franchise overlaps with Exocel Bio's emerging wound-healing use case (e.g., Palomar Health).

TypeDirect peer
Description

US-based exosome company offering MSC-derived exosome products for aesthetics, sports medicine, and wellness. Direct competitor with overlapping core technology (MSC exosomes), manufacturing claims, and practitioner-focused distribution.

TypeBroad incumbent
Description

Global dermatology and aesthetics leader (Sculptra, Restylane, Dysport) competing in medical aesthetics. Comparable as the broad incumbent targeting dermatologists and aesthetic clinics; Exocel Bio is a niche add-on to Galderma's regenerative-adjacent portfolio.

9Evoq Health
TypeEmerging player
Description

Emerging exosome therapeutics and skincare brand focused on professional regenerative applications. Comparable in category and customer base, but smaller scale and narrower product line than Exocel Bio.

TypeBroad incumbent
Description

Global medical aesthetics company (Xeomin, Radiesse, Ultherapy) with strong dermatology channel presence. Comparable broad incumbent serving the same medical spas and aesthetic practices that Exocel Bio targets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Exocel Bio

Regenerative Aesthetics Biologicsexocelbio.com

What Exocel Bio does

Exocel Bio is a privately held biotechnology company that designs and manufactures mesenchymal stem cell (MSC)-derived exosome products for professional regenerative aesthetics. The company operates under cGMP and ISO standards at a state-of-the-art GMP cleanroom facility located at the Pennsylvania Biotechnology Center in Doylestown, and sells exclusively to licensed clinicians rather than consumers. Its core brand, exovex, spans exovex Skin (5B, 12B, 25B exosome concentrations), exovex+ Skin (5 Trillion EVs with a multi-component bioactive complex), and exovex+ Hair (7B, 15B, 30B concentrations), plus research-grade exosomes (75B, 100B, 450B) and a custom concentration service for academic and biotech researchers.

The company's technical differentiation rests on a proprietary 9-step manufacturing process, tangential flow filtration for large-scale GMP-compatible isolation, and third-party validation using ExoView chip assays, mass spectrometry, NGS, PCR, MudPIT, and NTA to verify exosome identity (CD9, CD63, CD81 markers), purity, and potency. Research claims include over 500 specific growth factors and biomolecular cargo including mRNA, miRNA, collagen, keratin, and Wnt-pathway proteins. The company is exploring novel enhancements such as simulated microgravity and hypoxic culture conditions, presented at the SELECTBIO Space Summit 2025.

Exocel Bio generates revenue through one-time purchases of professional exosome serums and research-grade exosomes sold direct to clinics, medical spas, hair restoration practices, and academic institutions via a contact-based, quote-driven sales model. Distribution is domestic US only, supported by monthly Exovex Experiences webinars, Peer-to-Peer Physician Forums, and active participation in aesthetic and extracellular vesicle industry conferences. Scientific advisory board members from Harvard Medical School, Mount Sinai, and other leading institutions lend clinical and translational credibility to the offering.

Exocel Bio firmographics

Firmographics
Name
Exocel Bio
Legal name
Exocel Bio
Website
https://exocelbio.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Exocel Bio industry classification

Industry
Product category
Regenerative Aesthetics Biologics
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836), Perfumes, Cosmetics & Other Toilet Preparations (2844)
akta.pro industry
PRIMARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SECONDARYCRABAAAK
Professional/Backbar Skincare (Esthetician & Spa Use)

Keywords

  • Exosome skincare
  • Regenerative aesthetics
  • MSC-derived exosomes
  • Professional aesthetic biologics
  • Hair restoration serums

Where Exocel Bio is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Exocel Bio business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Professional Exosome Products: Sale of exovex branded exosome serums and solutions to licensed aesthetic clinics and medical professionals. Products include exovex Skin (5B, 12B, 25B concentrations) and exovex+ Hair (7B, 15B, 30B concentrations) and exovex+ Skin (5 Trillion EVs). Professional-use only, sold directly to practices.
  2. Custom Concentration Exosomes: Research-use exosomes at custom concentrations for academic and biotech research institutions. Products made to order with 3-4 week lead time, targeting specific concentration requirements for research or therapeutic applications.
  3. Research Exosome Products: Sale of bulk research-grade exosomes (75B, 100B, 450B concentrations) for research-only applications. Purified active exosomes suspended in medical-grade saline, free of additives and chemicals.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goREVIVE - 5 Billion exosomes for face revitalization
One time/ perpetual licensePay-as-you-goRENEW - 12 Billion exosomes for face and neck applications
One time/ perpetual licensePay-as-you-goREVEAL - 25 Billion exosomes for broad coverage
One time/ perpetual licensePay-as-you-goREFINE - 75 Billion exosomes for research use
One time/ perpetual licensePay-as-you-goRESTORE - 100 Billion exosomes for research use
One time/ perpetual licensePay-as-you-goEXOVEX+ HAIR - 7/15/30 Billion variants
One time/ perpetual licensePay-as-you-goexovex+ SKIN - 5 Trillion EVs

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

Exocel Bio product offering

Product offering

Core offering

Exocel Bio designs, manufactures, and sells exovex-branded MSC-derived exosome serums and solutions for professional skin rejuvenation and hair restoration, along with research-grade exosome products for academic and biotech use. All products are manufactured under cGMP and ISO standards at the Pennsylvania Biotechnology Center and are sold exclusively to licensed medical professionals and verified research institutions, not directly to consumers.

Product overview

Exocel Bio offers a unified portfolio of exosome-based regenerative products centered on its exovex® brand. The core offering includes exovex® Skin (available in 5B, 12B, and 25B concentrations) and exovex+ Skin (5 Trillion EVs with enhanced peptide complex) for skin rejuvenation, and exovex+ Hair (7B, 15B, 30B) for hair restoration. Supporting the professional product line are research-grade exosomes in 75B, 100B, and 450B concentrations, plus a custom concentration service for researchers. All products derive from MSC-derived exosomes and are intended exclusively for professional use.

Differentiator

Problem solved

Functional benefit

Brands

  • exovex+ SKIN: Professional-use exosome serum for skin rejuvenation, delivering 5 trillion extracellular vesicles with pure active intact exosomes, methylcobalamin, bioactive peptides, cytokines and growth factors.
  • exovex® SKIN
  • exovex+ HAIR

Products and services

  • exovex Skin Professional-use exosome serum designed to support visibly revitalized, healthier-looking skin through advanced cellular science. Powered by purified MSC-derived exosome-rich components, growth factors, and mRNA elements. Available in three concentrations: 5 Billion, 12 Billion, and 25 Billion exosomes per vial. For professional use only by licensed practitioners.
  • exovex+ Skin Advanced professional skin rejuvenation serum delivering 5 Trillion Extracellular Vesicles with six bioactive components including Pure Active Intact Exosomes, Methylcobalamin (Vitamin B12), Bioactive Peptides, Cytokines, and Growth Factors in a 5ML professional serum. Manufactured under GMP standards with sterility and endotoxin testing and full manufacturing traceability in a GMP-certified facility in the USA. For professional use only.
  • exovex+ Hair Professional hair treatment formulation with multi-factor complex including selected microRNAs (miR-10a, miR-21-5p, miR-26a-5p, miR-31, miR-146a-5p, miR-218-5p), peptides, vitamins, growth factors (FGF1/2/7/10, IGF-1/2, VEGFA, PDGF-A/B), cytokines, and Wnt pathway proteins. Available in 7 Billion, 15 Billion, and 30 Billion concentrations. For professional use only.
  • Research Exosomes (For Research Only) Highly concentrated, purified active exosomes suspended in medical-grade saline for research purposes. Free of additives and chemicals, available in 75 Billion, 100 Billion, and 450 Billion concentrations in 5ml vials, containing 500+ specific growth factors along with mRNA, miRNA, and proteins including collagen, keratin, elastin, and fibulin. For research use only.
  • Custom Concentration Exosomes Custom concentration exosome service for research applications, allowing researchers and biotech institutions to specify exact concentration requirements tailored to their research or therapeutic applications. Made-to-order with 3-4 week lead time.

Companies that use Exocel Bio

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Exocel Bio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Exocel Bio partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • University of PennsylvaniacoreStrategic or Co-development PartnerRenowned third-party collaborator and testing partner. Collaborates on scientific research and validation of exosome technology applications in regenerative medicine.
  • Blumberg InstitutecoreStrategic or Co-development PartnerCollaborating institution located at Pennsylvania Biotechnology Center. Provides research infrastructure and institutional partnership for exosome development. Dr. Aejaz Sayeed established institutional partnership between Blumberg Institute and Capital Health Hospital.
  • Rutgers UniversitycoreStrategic or Co-development PartnerRenowned academic collaborator contributing to scientific foundation of company's R&D efforts in exosome research.
  • UCLAcoreStrategic or Co-development PartnerAcademic research partner contributing to company's scientific research and development initiatives in regenerative medicine.
  • University of TorontocoreStrategic or Co-development PartnerInternational academic collaborator contributing to scientific foundation and ongoing research and development efforts.
  • Washington UniversitycoreStrategic or Co-development PartnerSelected as finalist in global pitch competition hosted in collaboration with WashU, recognizing innovative biotech solutions. Presentation addressed blood-brain barrier challenges and novel exosome-based approach for epilepsy treatment.
  • SELECTBIOminorGTM or Marketing PartnerConference organizer for The Space Summit 2025 and Extracellular Vesicles & Lipid Nanoparticles tracks. Platform for presenting research on space microgravity and hypoxia conditions for MSC-derived exosome enhancement.
  • Exodus SymposiumminorGTM or Marketing PartnerIndustry symposium on extracellular vesicles R&D. Natalia Tumidajski joined panel discussion on emerging technologies and bridging scientific innovation with scalable GMP manufacturing.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Exocel Bio competitors and assessment

Company assessment

Broad incumbents

  • AbbVie (Allergan Aesthetics): Global aesthetics leader (Botox, SkinMedica, CoolSculpting) with massive professional channel reach. Represents the broad incumbent benchmark that Exocel Bio's professional aesthetic clinic customers already transact with daily.
  • Galderma: Global dermatology and aesthetics leader (Sculptra, Restylane, Dysport) competing in medical aesthetics. Comparable as the broad incumbent targeting dermatologists and aesthetic clinics; Exocel Bio is a niche add-on to Galderma's regenerative-adjacent portfolio.
  • Merz Aesthetics: Global medical aesthetics company (Xeomin, Radiesse, Ultherapy) with strong dermatology channel presence. Comparable broad incumbent serving the same medical spas and aesthetic practices that Exocel Bio targets.

Direct peers

  • BENEV: US aesthetics and regenerative medicine company distributing exosome-based professional skincare lines. Comparable product portfolio, distribution model (B2B professional channel), and concentration-tier approach to exovex Skin/Hair.
  • ExoCoBio: Korea-based pioneer in stem cell-derived exosome cosmetics and therapeutics with established US distribution. Directly comparable as an MSC-derived exosome company targeting the same aesthetic dermatology channel with overlapping scientific claims and SKUs.
  • Rion Aesthetics: US-based aesthetics company commercializing placental-derived exosome products for skin rejuvenation and hair restoration. Closest direct competitor with overlapping product positioning, channel (aesthetic practices), and regenerative-biology messaging.
  • Kimera Labs: US-based exosome company offering MSC-derived exosome products for aesthetics, sports medicine, and wellness. Direct competitor with overlapping core technology (MSC exosomes), manufacturing claims, and practitioner-focused distribution.

Emerging players

  • Direct Biologics: US-based regenerative medicine company developing MSC-derived biologic products for wound care and orthopedic indications. Comparable emerging player in the broader exosome/MSC regenerative-medicine category Exocel Bio aspires to enter beyond aesthetics.
  • Evoq Health: Emerging exosome therapeutics and skincare brand focused on professional regenerative applications. Comparable in category and customer base, but smaller scale and narrower product line than Exocel Bio.

Others

  • Organogenesis: Regenerative medicine company (Apligraf, Dermagraft, NuShield) selling wound healing and surgical biologics. Comparable as an adjacent regenerative-medicine player whose wound-care franchise overlaps with Exocel Bio's emerging wound-healing use case (e.g., Palomar Health).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Exocel Bio social profiles

Digital presence

Exocel Bio compliance and trust

Trust signal

Compliance3 records

Exocel Bio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Exocel Bio leadership team

Management profile

Number of profiles

Profiles12 records

Exocel Bio funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Exocel Bio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Exocel Bio

What does Exocel Bio do?

Exocel Bio designs, manufactures, and sells exovex-branded MSC-derived exosome serums and solutions for professional skin rejuvenation and hair restoration, along with research-grade exosome products for academic and biotech use. All products are manufactured under cGMP and ISO standards at the Pennsylvania Biotechnology Center and are sold exclusively to licensed medical professionals and verified research institutions, not directly to consumers.

Is Exocel Bio a public or private company?

Exocel Bio is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Exocel Bio founded?

Exocel Bio was founded in 2020. It employs 11 to 50 people.

Where is Exocel Bio based?

Exocel Bio is headquartered in San Diego, United States, in the North America region.

How does Exocel Bio make money?

Three revenue lines are on record. Professional Exosome Products are the primary driver. The others are custom Concentration Exosomes and research Exosome Products.

Who are Exocel Bio's main competitors?

Broad incumbents on record are AbbVie (Allergan Aesthetics), Galderma and Merz Aesthetics. Direct peers are BENEV, ExoCoBio, Rion Aesthetics and Kimera Labs. Emerging players are Direct Biologics and Evoq Health. Organogenesis is listed as an others.

Does Exocel Bio have an API?

No public API is recorded for Exocel Bio.

What industry is Exocel Bio in?

Exocel Bio's product category is Regenerative Aesthetics Biologics. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals, with a secondary code of CRABAAAF, Dermocosmetics & Medical-Grade Skincare. Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals